24 Jun 2013
Eli Lilly and Co have announced that late-stage trials on their their once-weekly type 2 diabetes drug have shown better results in controlling blood sugar levels than similar medicines. The results were presented at the American Diabetes Association meeting.
New Awards Committee Chair
29 Jan 2025
Society for Endocrinology endorses landmark guidelines for childhood pituitary tumour care
29 Jan 2025
Announcing the Winners of the SfE Emerging Researcher Lectures 2025
23 Jan 2025
Congratulations to the awardees of our third round of 2024 grants
22 Jan 2025